Icecure MedicalICCM

13F holders, Q3 2024 (September 30)
15holders +1
4new positions
3sold out
$0.60avg. 13F price*

At the end of Q3 2024, 15 institutions reported holding Icecure Medical Ltd. (ICCM) in their 13F filings, up 1 from Q2 2024. 4 opened new positions and 3 sold out. The largest holders were UBS Group AG ($37K), XTX Topco Ltd ($16K) and Geode Capital Management, LLC ($16K).

Company
Icecure Medical Ltd.
CUSIP
M53071136
Latest filing quarter
Q1 2026

History

Number of 13F holders

05101520 Q1 2024: 12Q1 2024Q2 2024: 14Q2 2024Q3 2024: 15Q3 2024Q4 2024: 13Q4 2024Q1 2025: 14Q1 2025Q2 2025: 18Q2 2025Q3 2025: 17Q3 2025Q4 2025: 19Q4 2025Q1 2026: 18Q1 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions4$62K
Exits3$187K

All 13F filers, Q2 2024 → Q3 2024: 102,197 shares bought and 268,254 shares sold, net −166,057 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

UBS Group AG 0.00% New 59,894 $37K
XTX Topco Ltd 0.00% New 26,311 $16K
Geode Capital Management, LLC 0.00% No change 25,560 $16K
Two Sigma Investments, LP 0.00% Reduce -12.8% 18,525 $11K
Virtu Financial LLC 0.00% Reduce -46.4% 14,577 $9K
HRT Financial LP 0.00% New 13,492 $8K
Concurrent Investment Advisors, LLC 0.00% No change 10,000 $6K
Foundations Investment Advisors, LLC 0.00% No change 10,000 $6K
Morgan Stanley 0.00% No change 6,069 $4K
JPMorgan Chase & Co. 0.00% No change 5,950 $4K
Avion Wealth 0.00% New 2,500 $1K
Bank of America Corp. 0.00% No change 862 $526
Tower Research Capital LLC (TRC) 0.00% No change 294 $179
Bartlett & Co. Wealth Management LLC 0.00% No change 250 $153
Royal Bank of Canada 0.00% No change 1,087 $0

"% of holder's portfolio" is ICCM's weight in each manager's 13F, not the share of Icecure Medical Ltd. the manager owns.